Vermilion

Member
  • Content count

    102
  • Joined

  • Last visited


Community Reputation

6 Neutral

About Vermilion

Member

Profile Information

  • Gender Male

Achievements

Bronze Poster
Posted at least 100 different posts
20 posts
100 posts
500 posts
2000 posts
No reviews awards
Review at least 1 product
1 product
5 products
10 products
25 products

Recent Profile Visitors

1,218 profile views
  1. 4/17/16 - 5/12/16 Day 240 - 265: Nothing really much to update on. I have not had an acne spot in months. Still slightly oily after six hours. Other than that, all good.
  2. 4/10/16 - 4/16/16 Day 233 - 239: Same effects as usual. Have about ~100 days left of accutane pills left.
  3. 4/3/16 - 4/9/16 Day 226 - 232: Developed a zit right at my left jawline. Other than that, just the usual side effects.
  4. Sebum Inhibiting Drugs Currently in Clinical Trials

    Update: So DRM01 phase 2b results will be provided in the second quarter of 2016. SB204 phase 3 has just placed their first patient and will have results in the second half of 2017. http://investor.dermira.com/phoenix.zhtml?c=253686&p=irol-newsArticle&ID=2127466 http://www.novantherapeutics.com/investors-media/press-releases/first-patient-dosed-phase-3-program-sb204/
  5. 3/26/16 - 4/2/16 Day 218 - 225: I still need to a use an oil absorbing sheet six hours after cleansing. I still only have dry skin and have yet to have much acne at all.
  6. 3/19/16 - 3/25/16 Day 211 - 217: Still not much to report besides what has happened the past few months.
  7. 3/12/16 - 3/18/16 Day 204 - 2010: Still nothing to update.
  8. 3/5/16 - 3/11/16 Day 197 - 203: Not much to update. No acne except for one on my upper throat area. Probably due to shaving. Only have a few more months of this treatment, but not encountering the many issues others have reported. My skin in general is tough.
  9. 2/27/16 - 3/4/16 Day 190 - 196: Same as usual. Currently no acne except for one on my chest. It is quite persistent and has been there for quite a while. Cannot pop or anything.